Archived Webinars

TASA ID: 4407

On December 4, 2014, The TASA Group in conjunction with senior options trader and consultant, Larry Pines presented a free, one-hour webinar presentation, Equities and Derivatives: Essential Forensic Tools for Litigators.

The webinar introduced and explored key tools that litigation professionals and associates can use to critically examine financial market data.  Mr. Pines explored the following:

1. Strategies for investigating and analyzing financial market data for signs of fraud or misconduct.
2. Common pitfalls that lead forensic accountant to misinterpret market data and draw false conclusions.
3. The essential toolkit for performing bulletproof financial market analysis.

TASA ID: 1013

On November 20, 2014 The TASA Group in conjunction with transportation safety expert, Carl Berkowitz presented a free, one hour, interactive webinar presentation, Passenger Safety: Train and Bus, for all legal professionals.

This webinar cover common slips, trips and falls in the areas of transportation safety.  The program explored how numerous passengers suffer injuries each year and how those injuries can occur.  

TASA ID: 265

TASA ID:

On October 21, 2014, The TASA Group in conjunction with legal ethics expert, Jennifer Ellis presented a free, one-hour, interactive webinar presentation, Ethics for Lawyers: Using Facebook, Twitter and LinkedIn for Legal Marketing for all legal professionals.

This presentation discussed social media ethics for lawyers and covered how to use Facebook, Twitter and LinkedIn for legal marketing. Ms. Ellis discussed intent of social media marketing and advertising rules. She also provided examples of best practices, as well as ethical issues that may arise when promoting a law firm on social media.  

TASA ID: 248

On October 7, 2014, The TASA Group in conjunction with medical device expert, Dr. Edward Reese presented a free, one-hour, interactive webinar presentation, The Implications of Medical Device Labeling, for all legal professionals.

This webinar discussed the implications of medical device labeling that could contribute to, or directly cause, a patient serious injury or death. Dr. Reese provided information about the established laws and regulations that govern device-labeling requirements. He also discussed commercial distribution, as well as Design Objective Intent.